Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the Indian generics giant into a global leader in branded and innovative medicines. Sun Pharma is competing…
Read More
The Mythos and Agentic AI debates, are not just about one model or one company. They are about the next phase of financial AI, where systems evolve from assisting decisions to actively shaping them. This transition will inevitably require a…
Read More
SBI Life’s VNB margins are expected to remain stable in the 27–28% range in FY27, aided by product diversification and pricing discipline. Even after absorbing GST-related impact, the margin profile has remained resilient, indicating strong underlying profitability.
Read More
The minutes of the April policy meeting, where the MPC unanimously held the repo rate at 5.25% and retained a neutral stance, indicate that policymakers are viewing the current inflationary pressures as supply-driven and are willing to look through first-round…
Read More
Oil prices surged for a fifth consecutive day, fueled by escalating Middle East tensions. Iran’s actions in the Strait of Hormuz and reports of air defense engagement have heightened concerns. Analysts predict further price hikes if U.S.-Iran negotiations falter, with…
Read More
Infosys shares saw a 6% drop following a forecast of 1.5% to 3.5% revenue growth for FY27. The company reported strong large deal wins and resilient underlying demand. Despite geopolitical uncertainty, Infosys is strengthening its capabilities through acquisitions. Hiring continues…
Read More